Critical Care & Emergencies
Gastrointestinal complications in critically ill patients with and without COVID-19
25 Sep, 2020 | 02:44h | UTCGastrointestinal Complications in Critically Ill Patients With and Without COVID-19 – JAMA
Commentary on Twitter
#Covid patients have higher incidence of GI complications incl. mesenteric ischemia than propensity score-matched patients without #Covid. Check out our research letter @JAMA_current https://t.co/9RhC4t3JQ5 @ElmohebM @leon_naar @mathiasac @CarolijnKapoen @MahaFarhat @hayfarani
— Lydia Maurer (@LMaurerMD) September 24, 2020
Small randomized trial evaluated intravenous methylprednisolone pulse as a treatment for hospitalized severe COVID-19 patients
25 Sep, 2020 | 02:41h | UTC
Understanding necrotizing soft tissue infections in the intensive care unit
25 Sep, 2020 | 02:31h | UTC
Commentary on Twitter
Necrotizing soft tissue infections in #ICU, focus on optimizing interventions most likely to impact outcome:
➡️ keep high index of suspicion vs misdiagnosis/delays in starting treatment
➡️ coordinate urgent approach: early debridement + broad-spectrum ABThttps://t.co/NpkxYFHbGl pic.twitter.com/8LDQuOGobI— Intens Care Med (@yourICM) September 22, 2020
JAMA Network Series: Medical Specialties and the COVID-19 Pandemic
24 Sep, 2020 | 09:45h | UTCEditorial: The COVID-19 Pandemic and the JAMA Network
See articles:
- Cardiology and COVID-19
- Dermatology and COVID-19
- Internal Medicine and COVID-19
- Nephrology and COVID-19
- Neurology and COVID-19
- Oncology and COVID-19
- Ophthalmology and COVID-19
- Otolaryngology–Head and Neck Surgery and COVID-19
- Pediatrics and COVID-19
- Psychiatry and COVID-19
- Surgery and COVID-19
- JAMA Network Open and COVID-19
- JAMA Health Forum and COVID-19
Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection
24 Sep, 2020 | 09:32h | UTCCommentary: Simple blood test can predict severity of COVID-19 for some patients – University of Texas Health Science Center at Houston AND Routine blood test may identify patients at risk for severe COVID-19 – UPI
Commentary on Twitter
Death in #COVID19: JAMA Open
In lots of dzs RDW >14.5% robustly risk stratifies pts w/in illness. True in #COVID! Mortality w/ nl RDW 11% vs. 31% with high RDW (9% ⬆️ risk per 0.5% increase in RDW). BEST predictor next to Age!https://t.co/aZJ3p488cN#medtwitter #tipsfornewdocs pic.twitter.com/967g2HElYH— WesElyMD (@WesElyMD) September 23, 2020
COVID-19 can affect the heart
24 Sep, 2020 | 09:30h | UTCCOVID-19 can affect the heart – Science
Commentary on Twitter
"These complications, which at times are the only features of #COVID19 clinical presentation, have occurred even in cases with mild symptoms and in people who did not experience any symptoms" https://t.co/q42cY3ujV4
a 🧵to explain 1/— Eric Topol (@EricTopol) September 24, 2020
Things we do for no reason: Routine correction of elevated INR and thrombocytopenia prior to paracentesis in patients with cirrhosis
24 Sep, 2020 | 09:17h | UTCSee collection: Choosing Wisely: Things We Do For No Reason – Journal of Hospital Medicine
Things we do for no reason: Routine coverage of anaerobes in aspiration pneumonia
24 Sep, 2020 | 09:17h | UTCSee collection: Choosing Wisely: Things We Do For No Reason – Journal of Hospital Medicine
[Preprint] Randomized trial: Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers
23 Sep, 2020 | 14:17h | UTC
Commentary on Twitter
🔥 #Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial 🔥
-1st RCT on HCQ as PrEP
-1483 HCW randomized to HCQ 1x or 2x weekly or placebo
-No difference in development of confirmed or probable COVID19 https://t.co/Gn1otqKhrW pic.twitter.com/3r0HB56h9y
— Ilan Schwartz MD PhD (@GermHunterMD) September 21, 2020
COVID-19 clinical trials: Learning from exceptions in the research chaos
23 Sep, 2020 | 14:50h | UTCCOVID-19 clinical trials: learning from exceptions in the research chaos – Nature
Commentary on Twitter
Our analysis on #COVID clinical trials on Nature Medicine. Only big randomised trials can answer rapidly & reliably. Megatrials need support from regulators, funders, health services, docs. Pre-existing trial networks helpful. Collaboration key to success. https://t.co/YlalAEMR9r pic.twitter.com/wElfXfXdol
— Kari Tikkinen (@KariTikkinen) September 22, 2020
Catheter-associated urinary tract infections in adults: diagnosis, treatment, and prevention
23 Sep, 2020 | 14:35h | UTCCatheter-Associated Urinary Tract Infections in Adults: Diagnosis, Treatment, and Prevention – Journal of Hospital Medicine (free for a limited period)
The core lesson of the COVID-19 heart debate
22 Sep, 2020 | 10:00h | UTCThe Core Lesson of the COVID-19 Heart Debate – The Atlantic
Commentary on Twitter
The Atlantic does a fantastic job in presenting balance. I'm happy I was able to contribute to this discussion about COVID and the heart in a small way. This is definitely worth the time to read #Covid #heart. https://t.co/gjtzZ7iRiy
— Paul Checchia (@ChecchiaPaul) September 21, 2020
Cardiac arrhythmias in critically ill patients with COVID-19: A brief review
22 Sep, 2020 | 09:59h | UTC
Ensuring adequate palliative and hospice care during COVID-19 surges
22 Sep, 2020 | 09:57h | UTCEnsuring Adequate Palliative and Hospice Care During COVID-19 Surges – JAMA
Commentary on Twitter
An ethical approach to #pandemic surge planning requires providing for patients seeking symptom relief & comfort at the end of life. Not to do so undermines patient, family trust, emotional health, and core values of society https://t.co/P0LeYuZwzt @MatthewWynia @CUPallCare
— JAMA (@JAMA_current) September 22, 2020
Hospital COVID-19 risk lowest among intensive care staff
22 Sep, 2020 | 09:53h | UTCHospital COVID-19 risk lowest among intensive care staff – MedicalXpress
Original Study: SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study – Thorax
Commentary on Twitter
HOT OF THE PRESS@ThoraxBMJ#Covid19UK#NHS hospital staff
Asymptomatic viral carriage
2.4%Seroprevalence
▶️ Housekeeping 34.5%
▶️ Acute medicine 33.3%
▶️ General internal medicine 30.3%
▶️ Intensive care 14.8%#protectNHSstaff#protectNHSpatientshttps://t.co/iqBKl3qLYD— Prof. Nicholas Hart (@NickHartThorax) September 12, 2020
Editorial: How severe COVID-19 infection is changing ARDS management
22 Sep, 2020 | 09:37h | UTCHow severe COVID-19 infection is changing ARDS management – Intensive Care Medicine
Concise review: Management of acute ischemic stroke
22 Sep, 2020 | 09:26h | UTCManagement of Acute Ischemic Stroke – Critical Care Medicine
Severe COVID-19 infections—knowledge gained and remaining questions
20 Sep, 2020 | 21:43h | UTCSevere COVID-19 Infections—Knowledge Gained and Remaining Questions – JAMA Internal Medicine
Commentary on Twitter
Just out @JAMAInternalMed – our editorial on what we've learned about severe #Covid19 pneumonia so far and what challenges are still ahead. Honored and proud to have written this together with Carolyn Calfee and Dan Brodie. https://t.co/rmVjUWNyvM
— Lieuwe Bos – Acute Pulmonary Medicine (@Acute_Pulmo_Med) September 18, 2020
[Preprint] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: An international collaborative meta-analysis of randomized trials
20 Sep, 2020 | 21:42h | UTC
Commentary on Twitter
This meta-analysis of 7,913 patients from 26 RCTs (16 unpublished) found no mortality benefit to #hydroxychloroquine or chloroquine in COVID19
Combined summary OR for all-cause mortality for HCQ 1.08, 95%CI 0.99-1.18
Confirms HCQ does not help, may harmhttps://t.co/4o9bXkOo5Q pic.twitter.com/QG1XMzN0da
— Ilan Schwartz MD PhD (@GermHunterMD) September 19, 2020
Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19
20 Sep, 2020 | 21:30h | UTC
Editorial: Convalescent plasma for Covid-19
20 Sep, 2020 | 21:29h | UTCConvalescent plasma for covid-19 – The BMJ
Commentary on Twitter
Last month the US FDA authorised the emergency use of convalescent plasma for hospital patients with covid-19. What evidence underpinned the FDA’s controversial decision? And will the authorisation make it more difficult to recruit participants for RCTS? https://t.co/PMO13J2IOq
— The BMJ (@bmj_latest) September 19, 2020
Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A narrative review
18 Sep, 2020 | 09:39h | UTC
The pooled prevalence of pulmonary embolism in patients with COVID-19
18 Sep, 2020 | 09:37h | UTCThe pooled prevalence of pulmonary embolism in patients with COVID-19 – Intensive Care Medicine
Commentary on Twitter
Pulmonary embolism in #COVID19, be careful! quantitative meta-analysis ->
pooled prevalence in pts undergoing #PE diagnosis 28%
higher pooled prevalence in pts admitted to #ICU vs those admitted to non-ICU: 19 vs 9%
Open access @yourICM #COVIDFOAM #FOAMcc https://t.co/dUqKAVoeCV pic.twitter.com/fvmQnTlv1M— Intens Care Med (@yourICM) September 15, 2020
How COVID-19 can damage the brain
17 Sep, 2020 | 09:36h | UTCHow COVID-19 can damage the brain – Nature
Commentary on Twitter
How COVID-19 can damage the brain https://t.co/uQUS5y9AXU 125 people in the United Kingdom with COVID-19 who had neurological or psychiatric effects. 62% had strokes and haemorrhages, and 31% had altered mental states, such as confusion or prolonged unconsciousness.
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
CDC Study: Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19
17 Sep, 2020 | 09:29h | UTC
Commentary on Twitter
.@CDCMMWR report looking at almost 600 hospitalized pregnant women with #COVID19 found that pregnant women can have severe illness and poor birth outcomes, such as the mother requiring intensive care, pregnancy loss, and preterm birth. Learn more: https://t.co/g7WsFWJdDs. pic.twitter.com/Ve0dnGNTDM
— CDC (@CDCgov) September 16, 2020